● Dec 2008, April 2009:
   2M€ additional investment by Truffle Capital

● Dec 2008:
   OSEO supports Theraclion with a 8.5 M€ grant

● May 2008:
   First patient suffering from hyperparathyroidism is treated with
   Thyros

● Dec 2007: 
   OSEO supports Theraclion with a 1.3 M€ grant

● Nov 2007:
   Theraclion device is CE marked

● June 2006:
   First patient bearing a benign thyroid nodule is treated

● April 2005:
   Truffle Capital invests 3.5 M€ into Theraclion

● December 2004:
   Investment of “G1J” seed fund into Theraclion

● August 2004:
   Theraclion is founded with private capital by Jérôme Lebon† &
   François Lacoste. Feasibility clinical trials are pursued